Related Experiment Video
Updated: Mar 28, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Once-Daily Ceftriaxone Plus Metronidazole Versus Ertapenem and/or Cefoxitin for Pediatric Appendicitis
Amanda L Hurst1, Daniel Olson2,3, Stig Somme2,4
1Department of Pharmacy.
Insights
Ceftriaxone plus metronidazole (CTX plus MTZ) is an effective and cost-saving antibiotic regimen for pediatric appendicitis. This simplified treatment offers faster recovery and significant cost reductions compared to older methods.
Area of Science:
- Pediatric Surgery
- Infectious Diseases
- Pharmacoeconomics
Background:
- Appendicitis is a common pediatric surgical emergency requiring broad-spectrum antibiotics.
- Evaluating cost-effectiveness of simplified antibiotic regimens is crucial for pediatric care.
- Comparing historical antibiotic protocols with a ceftriaxone and metronidazole (CTX plus MTZ) regimen for appendicitis.
Observation:
- A retrospective review analyzed 841 pediatric appendicitis cases (nonperforated, perforated, abscessed).
- Outcomes measured included length of stay, time to afebrile, time to full feeds, and complication rates.
- Antibiotic costs were compared between historical (cefoxitin/ertapenem) and CTX plus MTZ regimens.
Findings:
- The CTX plus MTZ group demonstrated a significantly shorter time to afebrile status (P < .001).
- No significant differences were observed in length of stay or postoperative abscess/infection rates between treatment groups.
- Total antibiotic cost savings exceeded $110,000 with the CTX plus MTZ regimen.
Implications:
- Ceftriaxone plus metronidazole (CTX plus MTZ) is an effective and safe alternative for treating pediatric appendicitis.
- This regimen offers improved patient recovery metrics (time to afebrile) and substantial cost savings.
- Streamlined antibiotic protocols like CTX plus MTZ can optimize resource allocation in pediatric surgical care.
Background:
Appendicitis is a common surgical emergency in pediatric patients, and broad-spectrum antibiotic therapy is warranted in their care. A simplified once-daily regimen of ceftriaxone and metronidazole (CTX plus MTZ) is cost effective in perforated patients. The goal of this evaluation is to compare a historic regimen of cefoxitin (CFX) in nonperforated cases and ertapenem (ERT) in perforated and abscessed cases with CTX plus MTZ for all cases in terms of efficacy and cost.
Methods:
A retrospective review compared outcomes of nonperforated, perforated, and abscessed cases who received the historic regimen or CTX plus MTZ. Length of stay, time to afebrile, time to full feeds, postoperative abscess, and wound infection rates, inpatient readmissions, and antibiotic costs were evaluated.
Results:
There were a total of 841 cases reviewed (494 nonperforated, 247 perforated, and 100 abscessed). Overall, the CTX plus MTZ group had a shorter time to afebrile (P < .001). Treatment groups did not differ in length of stay. Postoperative abscess rates were similar between groups (4.1% vs 3.3%, not significant). Other postoperative complications were similar between groups. Total antibiotic cost savings were over $110 000 during the study period (from November 2010 to June 2013).
Conclusions:
Both CFX and/or ERT and CTX plus MTZ result in low abscess and complication rates, suggesting both are effective strategies. Treatment with CTX plus MTZ results in a shorter time to afebrile, while also providing significant antibiotic cost savings. Ceftriaxone plus MTZ is a streamlined, cost-effective regimen in the treatment of nonperforated, perforated, and abscessed appendicitis.
Related Concept Videos
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
